QED Bioscience

Novel monoclonal and polyclonal antibodies

QED Bioscience has been designing and manufacturing antibodies for over 20 years, and throughout its history, their goals have remained unchanged: provide the best antibody products and services on the market and support their clients with the expertise and assistance they should expect from a full-spectrum antibody company.


QED Bioscience develops novel monoclonal and polyclonal antibody products for our academic, biotechnology, diagnostic and pharmaceutical research clients. These antibodies are developed using the client’s small molecule, protein, or peptide targets, or by utilizing the target cDNA. QED is a full-service corporation, and offers additional immunochemistry services such as purification and conjugation so to provide clients with an antibody product that will work specifically within their system. QED Bioscience also develops monoclonal antibodies with pharmacological activity for enzyme neutralization and inhibition of receptor-ligand interactions, and anti-idiotypic antibodies.

 

Product Range:

- Antibodies
- Recombinant Proteins
- Chemokines
- SERION Immunologics Native and Recombinant Antigens
- Infectious Disease Test Kits
- Cell Culture Products

https://www.qedbio.com/

Show Product

Other Partners

Krishgen Biosystems

Krishgen Biosystems

Immunoassays for Life Sciences

Arlington Scientific

Arlington Scientific

Non-Mammalian Blocking Buffers

FuGENE

FuGENE

Transfection Reagents Empowering Biomedical Discovery

Columbia Biosciences

Columbia Biosciences

Fluorescent Proteins and Antibody Conjugates

REPROCELL

Reprocell

Stem cell research and 3D bioengineered tissues